SEC Company Response from Rein Therapeutics, Inc. (RNTX) (CIK 0001420565) (RNTX) — Jun 26, 2017
Rein Therapeutics, Inc. (RNTX) (CIK 0001420565)
Date: June 26, 2017 · CIK: 0001420565 · Accession: 0001193125-17-213215
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218474
Letter
Acceleration Request
AILERON THERAPEUTICS, INC.
281 Albany Street
Cambridge, MA
June 26, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: Aileron Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-218474
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-218474), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on June 28, 2017, or as soon thereafter as practicable.
* * * *
Very truly yours,
AILERON THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request AILERON THERAPEUTICS, INC. 281 Albany Street Cambridge, MA 02139 June 26, 2017 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Aileron Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-218474 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-218474), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on June 28, 2017, or as soon thereafter as practicable. * * * * Very truly yours, AILERON THERAPEUTICS, INC. By: /s/ Joseph A. Yanchik III Name: Joseph A. Yanchik III Title: President and Chief Executive Officer cc: Stuart M. Falber, Wilmer Cutler Pickering Hale and Dorr LLP Joshua D. Fox, Wilmer Cutler Pickering Hale and Dorr LLP Peter N. Handrinos, Latham & Watkins LLP